These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 24326563)
1. Therapy for alopecia areata in mice using parathyroid hormone agonists and antagonists, linked to a collagen-binding domain. Katikaneni R; Gulati R; Suh D; Sakon J; Seymour A; Ponnapakkam T; Gensure R J Investig Dermatol Symp Proc; 2013 Dec; 16(1):S61-2. PubMed ID: 24326563 [TBL] [Abstract][Full Text] [Related]
2. Therapy for Alopecia Areata in Mice by Stimulating the Hair Cycle with Parathyroid Hormone Agonists Linked to a Collagen-Binding Domain. Katikaneni R; Seymour AW; Gulati R; Ponnapakkam T; Gensure RC J Investig Dermatol Symp Proc; 2015 Nov; 17(2):13-5. PubMed ID: 26551937 [TBL] [Abstract][Full Text] [Related]
3. Treatment for chemotherapy-induced alopecia in mice using parathyroid hormone agonists and antagonists linked to a collagen binding domain. Katikaneni R; Ponnapakkam T; Suda H; Miyata S; Sakon J; Matsushita O; Gensure RC Int J Cancer; 2012 Sep; 131(5):E813-21. PubMed ID: 22130912 [TBL] [Abstract][Full Text] [Related]
4. Treatment and prevention of chemotherapy-induced alopecia with PTH-CBD, a collagen-targeted parathyroid hormone analog, in a non-depilated mouse model. Katikaneni R; Ponnapakkam T; Matsushita O; Sakon J; Gensure R Anticancer Drugs; 2014 Jan; 25(1):30-8. PubMed ID: 24025564 [TBL] [Abstract][Full Text] [Related]
5. Normalisation of hair follicle morphology in C3H/HeJ alopecia areata mice after treatment with squaric acid dibutylester. Gardner S; Freyschmidt-Paul P; Hoffmann R; Sundberg JP; Happle R; Lindsey NJ; Tobin DJ Eur J Dermatol; 2000 Aug; 10(6):443-50. PubMed ID: 10980465 [TBL] [Abstract][Full Text] [Related]
6. Parathyroid hormone linked to a collagen binding domain promotes hair growth in a mouse model of chemotherapy-induced alopecia in a dose-dependent manner. Katikaneni R; Ponnapakkam T; Seymour A; Sakon J; Gensure R Anticancer Drugs; 2014 Aug; 25(7):819-25. PubMed ID: 24710191 [TBL] [Abstract][Full Text] [Related]
7. Successful treatment of alopecia areata-like hair loss with the contact sensitizer squaric acid dibutylester (SADBE) in C3H/HeJ mice. Freyschmidt-Paul P; Sundberg JP; Happle R; McElwee KJ; Metz S; Boggess D; Hoffmann R J Invest Dermatol; 1999 Jul; 113(1):61-8. PubMed ID: 10417620 [TBL] [Abstract][Full Text] [Related]
8. Autoantibodies to hair follicles in C3H/HeJ mice with alopecia areata-like hair loss. Tobin DJ; Sundberg JP; King LE; Boggess D; Bystryn JC J Invest Dermatol; 1997 Sep; 109(3):329-33. PubMed ID: 9284100 [TBL] [Abstract][Full Text] [Related]
9. Parathyroid hormone-related peptide and the hair cycle - is it the agonists or the antagonists that cause hair growth? Gensure RC Exp Dermatol; 2014 Dec; 23(12):865-7. PubMed ID: 25041375 [TBL] [Abstract][Full Text] [Related]
10. A new strategy for modulating chemotherapy-induced alopecia, using PTH/PTHrP receptor agonist and antagonist. Peters EM; Foitzik K; Paus R; Ray S; Holick MF J Invest Dermatol; 2001 Aug; 117(2):173-8. PubMed ID: 11511291 [TBL] [Abstract][Full Text] [Related]
11. Fas-deficient C3.MRL-Tnfrsf6(lpr) mice and Fas ligand-deficient C3H/HeJ-Tnfsf6(gld) mice are relatively resistant to the induction of alopecia areata by grafting of alopecia areata-affected skin from C3H/HeJ mice. Freyschmidt-Paul P; McElwee KJ; Botchkarev V; Kissling S; Wenzel E; Sundberg JP; Happle R; Hoffmann R J Investig Dermatol Symp Proc; 2003 Jun; 8(1):104-8. PubMed ID: 12895005 [TBL] [Abstract][Full Text] [Related]
12. Topical mechlorethamine restores autoimmune-arrested follicular activity in mice with an alopecia areata-like disease by targeting infiltrated lymphocytes. Tang L; Cao L; Bernardo O; Chen Y; Sundberg JP; Lui H; Chung S; Shapiro J J Invest Dermatol; 2003 Mar; 120(3):400-6. PubMed ID: 12603852 [TBL] [Abstract][Full Text] [Related]
13. 2-deoxy D-glucose treatment does not elicit a hair growth response in alopecia areata. Sundberg JP; Silva KA; Kennedy VE; Wilson JJ; Gott NE; Sundberg BA; Roopenian DC Exp Dermatol; 2019 Sep; 28(9):1091-1093. PubMed ID: 31323149 [TBL] [Abstract][Full Text] [Related]
14. The antiinflammatory effects of Xuefu Zhuyu decoction on C3H/HeJ mice with alopecia areata. He X; Duan X; Liu J; Sha X; Gong Y; Lu W; Li Z; Chen X; Li Y; Shen Z Phytomedicine; 2021 Jan; 81():153423. PubMed ID: 33310308 [TBL] [Abstract][Full Text] [Related]
15. Substance P as an immunomodulatory neuropeptide in a mouse model for autoimmune hair loss (alopecia areata). Siebenhaar F; Sharov AA; Peters EM; Sharova TY; Syska W; Mardaryev AN; Freyschmidt-Paul P; Sundberg JP; Maurer M; Botchkarev VA J Invest Dermatol; 2007 Jun; 127(6):1489-97. PubMed ID: 17273166 [TBL] [Abstract][Full Text] [Related]
16. Treatment of alopecia areata in C3H/HeJ mice with the topical immunosuppressant FK506 (Tacrolimus). Freyschmidt-Paul P; Ziegler A; McElwee KJ; Happle R; Kissling S; Sundberg JP; Hoffmann R Eur J Dermatol; 2001; 11(5):405-9. PubMed ID: 11525945 [TBL] [Abstract][Full Text] [Related]
17. Controlled delivery of T-box21 small interfering RNA ameliorates autoimmune alopecia (Alopecia Areata) in a C3H/HeJ mouse model. Nakamura M; Jo J; Tabata Y; Ishikawa O Am J Pathol; 2008 Mar; 172(3):650-8. PubMed ID: 18245811 [TBL] [Abstract][Full Text] [Related]
18. Alopecia areata: a tissue specific autoimmune disease of the hair follicle. Gilhar A; Kalish RS Autoimmun Rev; 2006 Jan; 5(1):64-9. PubMed ID: 16338213 [TBL] [Abstract][Full Text] [Related]
19. SOCS3 treatment prevents the development of alopecia areata by inhibiting CD8+ T cell-mediated autoimmune destruction. Gao Z; Jin YQ; Wu W Oncotarget; 2017 May; 8(20):33432-33443. PubMed ID: 28418931 [TBL] [Abstract][Full Text] [Related]